ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q8NBK3


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name SUMF1_HUMAN
Primary accession number Q8NBK3
Secondary accession numbers Q0VAC7 Q2NL78 Q53ZE4 Q6UY39 Q96AK5 Q96DK8
Integrated into Swiss-Prot on July 25, 2003
Sequence was last modified on March 29, 2005 (Sequence version 3)
Annotations were last modified on    July 22, 2008 (Entry version 64)
Name and origin of the protein
Protein name Sulfatase-modifying factor 1 [Precursor]
Synonyms EC 1.13.-.-
C-alpha-formyglycine-generating enzyme 1
Gene name
Name: SUMF1
Synonyms: FGE
ORFNames: PSEC0152, UNQ3037/PRO9852
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS MSD VAL-279; ARG-336; GLN-349 AND TRP-349, AND VARIANT ASN-63.
DOI=10.1016/S0092-8674(03)00347-7; PubMed=12757705 [NCBI, ExPASy, EBI, Israel, Japan]
Dierks T., Schmidt B., Borissenko L.V., Peng J., Preusser A., Mariappan M., von Figura K.;
"Multiple sulfatase deficiency is caused by mutations in the gene encoding the Homo sapiens C-alpha-formyglycine-generating enzyme.";
Cell 113:435-444(2003).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS MSD PRO-155; TYR-218; ARG-336; CYS-345; PRO-348; GLN-349 AND TRP-349, AND FUNCTION.
DOI=10.1016/S0092-8674(03)00348-9; PubMed=12757706 [NCBI, ExPASy, EBI, Israel, Japan]
Cosma M.P., Pepe S., Annunziata I., Newbold R.F., Grompe M., Parenti G., Ballabio A.;
"The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.";
Cell 113:445-456(2003).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT ASN-63.
DOI=10.1101/gr.1293003; PubMed=12975309 [NCBI, ExPASy, EBI, Israel, Japan]
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.";
Genome Res. 13:2265-2270(2003).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Gastric mucosa;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Placenta;
Ota T., Nishikawa T., Suzuki Y., Kawai-Hio Y., Hayashi K., Ishii S., Saito K., Yamamoto J., Wakamatsu A., Nagai T., Nakamura Y., Nagahari K., Sugano S., Isogai T.;
"HRI human cDNA sequencing project.";
Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Colon, and Prostate;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, MASS SPECTROMETRY, CALCIUM-BINDING, GLYCOSYLATION AT ASN-141, SUBCELLULAR LOCATION, AND DISULFIDE BONDS.
DOI=10.1074/jbc.M413383200; PubMed=15657036 [NCBI, ExPASy, EBI, Israel, Japan]
Preusser-Kunze A., Mariappan M., Schmidt B., Gande S.L., Mutenda K., Wenzel D., von Figura K., Dierks T.;
"Molecular characterization of the human Calpha-formylglycine-generating enzyme.";
J. Biol. Chem. 280:14900-14910(2005).
[8]
PARTIAL PROTEIN SEQUENCE, X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 73-374 IN COMPLEX WITH CALCIUM, GLYCOSYLATION AT ASN-141, MUTAGENESIS OF SER-333; CYS-336; HIS-337; TYR-340 AND CYS-341, AND DISULFIDE BONDS.
DOI=10.1016/j.cell.2005.03.001; PubMed=15907468 [NCBI, ExPASy, EBI, Israel, Japan]
Dierks T., Dickmanns A., Preusser-Kunze A., Schmidt B., Mariappan M., von Figura K., Ficner R., Rudolph M.G.;
"Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme.";
Cell 121:541-552(2005).
[9]
X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) OF MUTANTS SER-336 AND SER-341 IN COMPLEX WITH SULFATASE PEPTIDE.
DOI=10.1073/pnas.0507592102; PubMed=16368756 [NCBI, ExPASy, EBI, Israel, Japan]
Roeser D., Preusser-Kunze A., Schmidt B., Gasow K., Wittmann J.G., Dierks T., von Figura K., Rudolph M.G.;
"A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.";
Proc. Natl. Acad. Sci. U.S.A. 103:81-86(2006).
[10]
VARIANTS MSD PHE-20; PRO-177; TRP-224; ILE-259 AND LEU-266, AND CHARACTERIZATION OF VARIANTS MSD PHE-20; PRO-155; PRO-177; TYR-218; TRP-224; ILE-259; LEU-266; VAL-279; ARG-336; CYS-345; PRO-348; TRP-349 AND GLN-349.
DOI=10.1002/humu.20040; PubMed=15146462 [NCBI, ExPASy, EBI, Israel, Japan]
Cosma M.P., Pepe S., Parenti G., Settembre C., Annunziata I., Wade-Martins R., Domenico C.D., Natale P.D., Mankad A., Cox B., Uziel G., Mancini G.M., Zammarchi E., Donati M.A., Kleijer W.J., Filocamo M., Carrozzo R., Carella M., Ballabio A.;
"Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency.";
Hum. Mutat. 23:576-581(2004).
[11]
CHARACTERIZATION OF VARIANTS MSD PRO-177; SER-179; VAL-279 AND TRP-349.
DOI=10.1002/humu.9515; PubMed=18157819 [NCBI, ExPASy, EBI, Israel, Japan]
Schlotawa L., Steinfeld R., von Figura K., Dierks T., Gaertner J.;
"Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency.";
Hum. Mutat. 29:205-205(2008).
Comments
  • FUNCTION: Involved in 'Cys-type' sulfatase maturation under aerobic conditions. Converts newly synthesized inactive sulfatases to their active form by modifying an active site cysteine residue to 3-oxoalanine (also known as C(alpha)-formylglycine (FGly)). Known substrates include GALNS, ARSA, STS and ARSE.
  • PATHWAY: Protein modification; sulfatase oxidation.
  • SUBUNIT: Monomer. A small proportion (ca 15%) may exist as disulfide-linked homodimer.
  • SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
  • ALTERNATIVE PRODUCTS: 3 named isoforms [FASTA] produced by alternative splicing.
    Name1
    Isoform IDQ8NBK3-1
    This is the isoform sequence displayed in this entry.
    Name2
    Isoform IDQ8NBK3-2
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_007877.
    Name3
    Isoform IDQ8NBK3-3
    Features which should be applied to build the isoform sequence: VSP_013185.
  • TISSUE SPECIFICITY: Ubiquitous. Highly expressed in kidney, pancreas and liver. Detected at lower levels in leukocytes, lung, placenta, small intestine, skeletal muscle and heart.
  • PTM: N-glycosylated. Contains high-mannose-type oligosaccharides.
  • DISEASE: Defects in SUMF1 are the cause of multiple sulfatase deficiency (MSD) [MIM:272200]. MSD is a clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Inheritance is autosomal recessive.
  • SIMILARITY: Belongs to the sulfatase-modifying factor family.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=SUMF1";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AY208752; AAO34683.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY323910; AAP86217.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY358092; AAQ88459.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK057983; BAB71625.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK075459; BAC11634.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC017005; AAH17005.2; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC110862; AAI10863.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC121122; AAI21123.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
RefSeq NP_877437.2; -.
UniGene Hs.588682
3D structure databases
PDB
1Y1E; X-ray; 1.73 A; X=73-374.[ExPASy / RCSB / EBI]
1Y1F; X-ray; 1.80 A; X=73-374.[ExPASy / RCSB / EBI]
1Y1G; X-ray; 1.67 A; X=73-374.[ExPASy / RCSB / EBI]
1Y1H; X-ray; 1.67 A; X=73-374.[ExPASy / RCSB / EBI]
1Y1I; X-ray; 2.61 A; X=73-374.[ExPASy / RCSB / EBI]
1Y1J; X-ray; 1.55 A; X=73-374.[ExPASy / RCSB / EBI]
1Z70; X-ray; 1.15 A; X=73-374.[ExPASy / RCSB / EBI]
2AFT; X-ray; 1.66 A; X=86-371.[ExPASy / RCSB / EBI]
2AFY; X-ray; 1.49 A; X=86-371.[ExPASy / RCSB / EBI]
2AII; X-ray; 1.54 A; X=86-371.[ExPASy / RCSB / EBI]
2AIJ; X-ray; 1.55 A; X=86-371.[ExPASy / RCSB / EBI]
2AIK; X-ray; 1.73 A; X=86-371.[ExPASy / RCSB / EBI]
2HI8; X-ray; 1.64 A; X=86-371.[ExPASy / RCSB / EBI]
2HIB; X-ray; 2.00 A; X=86-371.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1Y1E; -.
1Y1F; -.
1Y1G; -.
1Y1H; -.
1Y1I; -.
1Y1J; -.
1Z70; -.
2AFT; -.
2AFY; -.
2AII; -.
2AIJ; -.
2AIK; -.
2HI8; -.
2HIB; -.
ModBase Q8NBK3.
Organism-specific databases
H-InvDB HIX0003013; -.
HGNC HGNC:20376; SUMF1.
GenAtlas SUMF1.
MIM 272200; phenotype. [NCBI / EBI]
607939; gene. [NCBI / EBI]
Orphanet 585; Mucosulfatidosis.
PharmGKB PA134977552; -.
GeneCards Q8NBK3.
Gene expression databases
ArrayExpress Q8NBK3; -.
CleanEx HS_SUMF1; -.
GermOnline ENSG00000144455; Homo sapiens.
Ontologies
GO
GO:0005788; Cellular component: endoplasmic reticulum lumen (inferred from electronic annotation from UniProtKB-SubCell).
QuickGo view.
Family and domain databases
InterPro IPR005532; SO4-mod_fac-like.
Graphical view of domain structure.
Gene3D G3DSA:3.90.1580.10; SO4-mod_fac-like; 1.
Pfam PF03781; DUF323; 1.
Pfam graphical view of domain structure.
BLOCKS Q8NBK3.
Genome annotation databases
Ensembl ENSG00000144455; Homo sapiens. [Contig view]
GeneID 285362; -.
KEGG hsa:285362; -.
Phylogenomic databases
HOVERGEN Q8NBK3; -.
Other
SOURCE SUMF1; Homo sapiens.
ProtoNet Q8NBK3.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Calcium; Direct protein sequencing; Disease mutation; Endoplasmic reticulum; Glycoprotein; Ichthyosis; Metachromatic leukodystrophy; Metal-binding; Mucopolysaccharidosis; Oxidoreductase; Polymorphism; Redox-active center; Signal.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    33  33      
CHAIN   34   374  341     Sulfatase-modifying factor 1. PRO_0000033456
REGION   341   360  20     Interaction with sulfatases. 
ACT_SITE   333   333        Proton acceptor (Probable). 
METAL   130   130        Calcium 2. 
METAL   259   259        Calcium 1. 
METAL   260   260        Calcium 1 (via carbonyl oxygen). 
METAL   273   273        Calcium 1. 
METAL   275   275        Calcium 1 (via carbonyl oxygen). 
METAL   293   293        Calcium 2 (via carbonyl oxygen). 
METAL   296   296        Calcium 2 (via carbonyl oxygen). 
METAL   298   298        Calcium 2 (via carbonyl oxygen). 
METAL   300   300        Calcium 2. 
CARBOHYD   141   141        N-linked (GlcNAc...). 
DISULFID   50    52         
DISULFID   218   365         
DISULFID   235   346         
DISULFID   336   341        Redox-active. 
VAR_SEQ   1    90        Missing (in isoform 2). VSP_007877
VAR_SEQ   340   374        YCYRYRCAARSQNTPDSSASNLGFRCAADRLPTMD -> QEYYDPYFQDVASEMLRRHTASRWKAFSSLEPCCSIRRHQ QYAAIERLTCGKFELRCASLRKIDCLNTNIACSYSMRQHG PRLHCVD (in isoform 3). VSP_013185
VARIANT   20    20  1     L -> F (in MSD; loss of activity). VAR_019050 
VARIANT   63    63  1     S -> N (in dbSNP:rs2819590 [NCBI]). VAR_016052 
VARIANT   155   155  1     S -> P (in MSD; loss of activity). VAR_016053 [3D]
VARIANT   177   177  1     A -> P (in MSD; loss of activity; decreases its specific enzyme activity to less than 1%; does not affect localization of the protein in the endoplasmic reticulum of MSD fibroblasts; protein stability is almost comparable to wild-type). VAR_019051 [3D]
VARIANT   179   179  1     W -> S (in MSD; decreases its specific enzyme activity to less than 3%; does not affect localization of the protein in the endoplasmic reticulum of MSD fibroblasts; protein stability is almost comparable to wild-type). VAR_042602 [3D]
VARIANT   218   218  1     C -> Y (in MSD; loss of activity). VAR_016054 [3D]
VARIANT   224   224  1     R -> W (in MSD; loss of activity). VAR_019052 [3D]
VARIANT   259   259  1     N -> I (in MSD; loss of activity). VAR_019053 [3D]
VARIANT   266   266  1     P -> L (in MSD; retains some activity). VAR_019054 [3D]
VARIANT   279   279  1     A -> V (in MSD; loss of activity; decreases its specific enzyme activity to about 23%; does not affect localization of the protein in the endoplasmic reticulum of MSD fibroblasts; protein stability is decreased). VAR_016055 [3D]
VARIANT   336   336  1     C -> R (in MSD; loss of activity). VAR_016056 [3D]
VARIANT   345   345  1     R -> C (in MSD; retains some activity). VAR_016057 [3D]
VARIANT   348   348  1     A -> P (in MSD; loss of activity). VAR_016058 [3D]
VARIANT   349   349  1     R -> Q (in MSD; loss of activity). VAR_016059 [3D]
VARIANT   349   349  1     R -> W (in MSD; loss of activity; decreases its specific enzyme activity to less than 1%; does not affect localization of the protein in the endoplasmic reticulum of MSD fibroblasts; protein stability is severely decreased). VAR_016060 [3D]
MUTAGEN   333   333        S->A: Loss of activity. 
MUTAGEN   333   333        S->T: Reduces activity by 99%. 
MUTAGEN   336   336        C->S: Loss of activity. 
MUTAGEN   337   337        H->A: Reduces activity 5-fold. 
MUTAGEN   340   340        Y->F: No effect. 
MUTAGEN   341   341        C->S: Loss of activity. 
CONFLICT   124   124        F -> L (in Ref. 5; BAC11634). 
CONFLICT   264   264        E -> D (in Ref. 5; BAC11634). 
STRAND   91    94  4      
STRAND   97   102  6      
HELIX   109   111  3      
STRAND   117   121  5      
STRAND   124   129  6      
HELIX   133   143  11      
HELIX   148   152  5      
STRAND   154   158  5      
HELIX   159   161  3      
STRAND   180   184  5      
HELIX   211   220  10      
HELIX   228   236  9      
HELIX   252   254  3      
TURN   265   267  3      
STRAND   293   305  13      
STRAND   315   317  3      
STRAND   325   331  7      
TURN   338   340  3      
STRAND   350   352  3      
STRAND   366   369  4      
Sequence information
Length: 374 AA [This is the length of the unprocessed precursor] Molecular weight: 40556 Da [This is the MW of the unprocessed precursor] CRC64: E64F2DF004C8CEA3 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MAAPALGLVC GRCPELGLVL LLLLLSLLCG AAGSQEAGTG AGAGSLAGSC GCGTPQRPGA 

        70         80         90        100        110        120 
HGSSAAAHRY SREANAPGPV PGERQLAHSK MVPIPAGVFT MGTDDPQIKQ DGEAPARRVT 

       130        140        150        160        170        180 
IDAFYMDAYE VSNTEFEKFV NSTGYLTEAE KFGDSFVFEG MLSEQVKTNI QQAVAAAPWW 

       190        200        210        220        230        240 
LPVKGANWRH PEGPDSTILH RPDHPVLHVS WNDAVAYCTW AGKRLPTEAE WEYSCRGGLH 

       250        260        270        280        290        300 
NRLFPWGNKL QPKGQHYANI WQGEFPVTNT GEDGFQGTAP VDAFPPNGYG LYNIVGNAWE 

       310        320        330        340        350        360 
WTSDWWTVHH SVEETLNPKG PPSGKDRVKK GGSYMCHRSY CYRYRCAARS QNTPDSSASN 

       370 
LGFRCAADRL PTMD 

Q8NBK3 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by br flag LNCC Brazil Mirror sites: Australia  Canada  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!